Literature DB >> 29507015

The mass effect of a slowly growing GIST.

Deepali Prakash1, Leandro Siragusa1, Saj Wajed2,3, Antonio Manzelli2,3.   

Abstract

Gastrointestinal stromal tumours (GISTs) are typically defined as solid masses arising from the GI tract, most commonly from the stomach and small intestine. They seldom present in a cystic form. Management of cystic masses arising from the GI tract may pose a diagnostic predicament. We had one such case that presented itself with complaints of a slow growing intra-abdominal mass. An ultrasound scan demonstrated a thick-walled cystic lesion arising from the pelvis. Further imaging evaluations in the form of a CT scan revealed a complex large cystic mass arising from left upper quadrant (see Figure 1). Due to the uncertainty of origin of this mass and lack of invasion or lymphadenopathy, it was thought to be benign. After a multidisciplinary meeting, it was concluded that an urgent surgical excision of this benign mass was the best treatment. The surgical treatment of which entailed a 10 hours surgery to resect this 10 kg lesion, which comprised 7 L fluid and 3 kg solid mass. Histopathology aided in the diagnosis of this lesion as a CD117-positive and DOG1-positive GIST. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cancer intervention; gastrointestinal surgery; gastrointestinal system; stomach and duodenum; surgical oncology

Mesh:

Substances:

Year:  2018        PMID: 29507015      PMCID: PMC5847848          DOI: 10.1136/bcr-2017-222556

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Multimodality imaging of pancreatic arteriovenous malformation.

Authors:  Wendy Hansen; Suresh Maximin; Jabi E Shriki; Puneet Bhargava
Journal:  Curr Probl Diagn Radiol       Date:  2014-09-26

2.  Monogenic and polygenic determinants of sarcoma risk: an international genetic study.

Authors:  Mandy L Ballinger; David L Goode; Isabelle Ray-Coquard; Paul A James; Gillian Mitchell; Eveline Niedermayr; Ajay Puri; Joshua D Schiffman; Gillian S Dite; Arcadi Cipponi; Robert G Maki; Andrew S Brohl; Ola Myklebost; Eva W Stratford; Susanne Lorenz; Sung-Min Ahn; Jin-Hee Ahn; Jeong Eun Kim; Sue Shanley; Victoria Beshay; Robert Lor Randall; Ian Judson; Beatrice Seddon; Ian G Campbell; Mary-Anne Young; Rajiv Sarin; Jean-Yves Blay; Seán I O'Donoghue; David M Thomas
Journal:  Lancet Oncol       Date:  2016-08-04       Impact factor: 41.316

Review 3.  Occurrence of other malignancies in patients with gastrointestinal stromal tumors.

Authors:  Abbas Agaimy; Peter H Wünsch; Leslie H Sobin; Jerzy Lasota; Markku Miettinen
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

4.  Rare cancers are not so rare: the rare cancer burden in Europe.

Authors:  Gemma Gatta; Jan Maarten van der Zwan; Paolo G Casali; Sabine Siesling; Angelo Paolo Dei Tos; Ian Kunkler; Renée Otter; Lisa Licitra; Sandra Mallone; Andrea Tavilla; Annalisa Trama; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2011-10-25       Impact factor: 9.162

Review 5.  Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

Authors:  Heikki Joensuu; Aki Vehtari; Jaakko Riihimäki; Toshirou Nishida; Sonja E Steigen; Peter Brabec; Lukas Plank; Bengt Nilsson; Claudia Cirilli; Chiara Braconi; Andrea Bordoni; Magnus K Magnusson; Zdenek Linke; Jozef Sufliarsky; Massimo Federico; Jon G Jonasson; Angelo Paolo Dei Tos; Piotr Rutkowski
Journal:  Lancet Oncol       Date:  2011-12-06       Impact factor: 41.316

6.  One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.

Authors:  Heikki Joensuu; Mikael Eriksson; Kirsten Sundby Hall; Jörg T Hartmann; Daniel Pink; Jochen Schütte; Giuliano Ramadori; Peter Hohenberger; Justus Duyster; Salah-Eddin Al-Batran; Marcus Schlemmer; Sebastian Bauer; Eva Wardelmann; Maarit Sarlomo-Rikala; Bengt Nilsson; Harri Sihto; Odd R Monge; Petri Bono; Raija Kallio; Aki Vehtari; Mika Leinonen; Thor Alvegård; Peter Reichardt
Journal:  JAMA       Date:  2012-03-28       Impact factor: 56.272

7.  Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.

Authors:  R E Bechtold; M Y M Chen; C A Stanton; P D Savage; E A Levine
Journal:  Abdom Imaging       Date:  2003 Nov-Dec

8.  UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST).

Authors:  Ian Judson; Ramesh Bulusu; Beatrice Seddon; Adam Dangoor; Newton Wong; Satvinder Mudan
Journal:  Clin Sarcoma Res       Date:  2017-04-21

9.  Unusual Appearance of a Pendulated Gastric Tumor: Always Think of GIST.

Authors:  Kristel De Vogelaere; Vanessa Meert; Frederik Vandenbroucke; Georges Delvaux; Anne Hoorens
Journal:  Case Rep Surg       Date:  2012-09-04

10.  Atypical presentation of gastrointestinal stromal tumor masquerading as a large duodenal cyst: A case report.

Authors:  Ameet Kumar; C K Jakhmola; Shivraj Singh Chauhan; Apoorv Singh
Journal:  Int J Surg Case Rep       Date:  2015-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.